- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 1–8 of 8
Introduction to Recombinant Activated Factor VII (rFVIIa)
Clinical Questions Addressed by the Comparative Effectiveness Review
Overview of In-Hospital, Off-Label vs. On-Label rFVIIa Use From the Premier Database (2000–2008)
Evidence for rFVIIa Use for Spontaneous Intracranial Hemorrhage vs. Usual Care
Overview of Comparative Effectiveness of rFVIIa for Spontaneous Intracranial Hemorrhage
Relative Hematoma Expansion Is Reduced After rFVIIa Use in Spontaneous Intracranial Hemorrhage
Increased Risk of Arterial Thromboembolic Events With rFVIIa for Spontaneous Intracranial Hemorrhage vs. Usual Care
Conclusions From Available Evidence
Your slide tray is being processed.